SCHEMBL2991069

SCHEMBL2991069

O=C(NC1CC1)C(=O)c1c(Cl)n(Cc2ccc(Cl)cc2Cl)c2ccc(Cl)cc12

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.43
CNR2 P34972 3/20 0.42
LMNA P02545 4/20 0.40
ALDH1A1 P00352 2/20 0.40
MAPT P10636 2/20 0.40
ALOX12 P18054 2/20 0.40
MEN1 O00255 1/20 0.40
ALPL P05186 1/20 0.40
ALPI P09923 1/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
KMT2A Q03164 1/20 0.40
EPHX2 P34913 3/20 0.39
SLC6A12 P48065 1/20 0.39
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
BACE1 P56817 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
F10 P00742 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2995773 0.96 ALDH1A1 (0.46) SIGMAR1CNR2LMNAALDH1A1MAPT
SCHEMBL3005711 0.96 LMNA (0.43) SIGMAR1CNR2LMNAALDH1A1MAPT
SCHEMBL2998712 0.95 ALDH1A1 (0.47) SIGMAR1CNR2LMNAALDH1A1MAPT
SCHEMBL3008409 0.94 L3MBTL1 (0.43) SIGMAR1CNR2LMNAALDH1A1MAPT
SCHEMBL2995185 0.93 CNR2 (0.41) SIGMAR1CNR2LMNAALDH1A1MAPT
SCHEMBL3001380 0.92 LMNA (0.48) SIGMAR1LMNAALDH1A1MAPTALOX12
SCHEMBL4378256 0.91 LMNA (0.45) SIGMAR1CNR2LMNAALDH1A1MAPT
SCHEMBL3005888 0.91 PLA2G2A (0.47) LMNAALDH1A1MAPTMEN1KMT2A
SCHEMBL3002533 0.90 MAPT (0.43) SIGMAR1CNR2LMNAALDH1A1MAPT
SCHEMBL2992509 0.90 L3MBTL1 (0.42) SIGMAR1CNR2LMNAALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100197708-A1 INDOLE COMPOUNDS WELLS FARGO BANK, NATIONAL ASSOCIATION 2010-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197708-A1 INDOLE COMPOUNDS IDO1, IDO2, TPH2 SIGMAR1 547/4885CNR2 20/4885LMNA 3450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.